Concerns over data manipulation lands Chinese API maker with US FDA Warning
The US FDA has hit cancer-drug API maker Yunnan Hande Bio-Tech with a warning letter citing concerns over potential manipulation of quality test data at a plant in China.
Archives for April 21, 2015
Recipharm in talks to make LIDDS' prostate cancer drug-device candidate
Recipharm has begun negotiations to manufacture a prostate cancer drug-device candidate for Swedish pharma firm LIDDS.
Genentech makes cell line identification faster and cheaper
Genentech scientists have created a faster, cheaper way to identify cell lines, a boon for CMOs and preclinical researchers.
Pfizer reveals PPD as third strategic CRO partner
Pfizer has selected PPD as its third preferred contract research organisation (CRO), but the addition will not affect ongoing relationships with Parexel and Icon, the firm says.
Dispatches from Interphex
Roundup of the day’s top news at Interphex
The world’s top pharma and biologics manufacturing and processing companies have come together in New York this week to showcase the latest in equipment and services.
Chinese drugmaker looks West in market expansion deal with ELC Group
Understanding international regulatory demands, manufacturing standards and overcoming cultural barriers are key for Asian drugmakers looking to enter Western markets, says market access CRO ELC Group.
Sigma-Aldrich opens doors to latest Singapore biopharma investment
Sigma-Aldrich has opened a cell culture Technical Center in Singapore and plans to expand further in the city-state with a cGMP distribution site.